News

Legal prohibition impacting Kettenbach/Xinial customers further clarified

Kettenbach/Xinial legally prevented from manufacture or offer for sale in Germany
Kettenbach/Xinial legally compelled to recall and destroy infringing system
medmix Switzerland Ltd. continues to enforce its rights

Ad hoc announcement pursuant to Art. 53 LR

Full-year 2023 revenue growth and profitability within communicated range
Improving trends expected throughout full-year 2024

medmix Switzerland Ltd. continues to enforce its rights

medmix Drug Delivery (Haselmeier) launches its passive needle safety device SicuroJect™ at Pharmapack Europe in Paris, further expanding its product portfolio.

medmix wins 2024 BIG Innovation Award for MIXPAC™ greenLine™ 400 mL 1:1 two-component cartridge set made from up to 100% recycled plastic.

Ad hoc announcement pursuant to Art. 53 LR

medmix (SIX: MEDX) today announced its intention to enter into a strategic investment, representing a 25% stake, in AARDEX to reinforce medmix' drug delivery business under the HaselmeierTM brand. AARDEX is a global Software as a Service (SaaS) provider of digital solutions for measuring and managing medication adherence in clinical trials.

medmix is excited to introduce ZerofloX, an innovative new flock-free micro applicator that provides a superior user experience for best esthetics.

medmix announces the sale of medmix Poland sp. z.o.o and the removal of this entity from sanctions list.

Ad hoc announcement pursuant to Art. 53 LR

Solid underlying business momentum in H1 2023 restrained by transitory factors

Strong performance expected in H2 2023 with mid-term outlook confirmed

New FY 2023 profit margin guidance reflects timing factors within H2 2023

medmix, a global leader in high-precision delivery devices, announces the successful completion of its acquisition of China-based Guangdong Qiaoyi Plastic Co. Ltd., following the announcement made in January 2023. This acquisition allows medmix to rapidly expand its global Beauty footprint in Asia.